Anna R. Mäkelä, PhD

CEO & Founder @Pandemblock | Senior Scientist @HelsinkiUni

[Rogelio Hernández-López @RogelioHdezL]

Excited to share our latest work! 🚀
We introduce sherpabodies, a modular, antibody-mimetic platform for CAR-T cell therapy targeting solid tumors. 🧫🔬🧬

Collaboration betweem the Saksela Lab @helsinkiuni and @CDI_UCSF

Check it out here: 🔗 https://t.co/DJDIAoRx2T

[Anna R. Mäkelä, PhD @Anna_R_Makela]

Our #sherpabody technology offers precision in targeting cancer cell therapies and efficiency in combating viral infections. Our latest research on #CARTcell therapy has just been published in Cancer Research.
https://t.co/nDniEPlLQQ
#cancertherapy

[University of Helsinki @helsinkiuni]

Researchers have developed a molecule that is, when administered nasally, extremely effective in preventing the infection of all known variants of the SARS-CoV-2 virus. The sherpabody-technology used can be a key tool in preparing for future pandemics.

➡️ https://t.co/rUyo8VJwsz

[University of Helsinki @helsinkiuni]

Tänään juhlistetaan maailman luovuuden ja innovaation päivää! 💡@UN

Tutkijamme ovat kehittäneet molekyylin, joka voi olla ratkaiseva ase varautumisessa tuleviin pandemioihin. Se estää nenään annosteltuna tehokkaasti kaikkien tunnettujen koronavirusmuunnosten aiheuttaman taudin.

[Health Digest @HealthDigestUS]

Could A Nasal Spray Be Your Next Line Of Defense Against COVID? https://t.co/Iy6N3fRr0P

[WebMD @WebMD]

An antiviral therapy in early development has the potential to prevent or treat COVID-19 infection when given as a nasal spray in as little as 4 hours before or after exposure. https://t.co/CSOylJlhKw

[Inside Precision Medicine @Inside_PM]

Finnish Researchers Develop Nasal Spray That Protects against #COVID

Researchers have developed a molecule for nasal administration to prevent development of #COVID19 symptoms by all known variants of the #SARSCoV2 virus. Learn more: https://t.co/43pQrXrO19

[Nature Portfolio @NaturePortfolio]

A paper in @NatureComms describes a small antibody-like protein that can prevent infection by diverse SARS-CoV-2 variants in cell culture and in mice that were intranasally treated with this inhibitor before or shortly after being exposed to the virus. https://t.co/57QqgYjt39

[delthia ricks 🔬 @DelthiaRicks]

In the lab: A nasal spray developed in Finland protects against #SARSCoV2 infection, including recent immune-evasive variants. When administered nasally the experimental molecule—TriSb92—developed at Univ of Helsinki blocks transmission & spread of #SARS2 https://t.co/P781w7eLbY

[Anna R. Mäkelä, PhD @Anna_R_Makela]

JUST OUT: #Intranasal highly stable trimeric #sherpabody inhibits #SARSCoV2 including recent immunoevasive Omicron subvariants - effective likely against future VOCs. #TriSb92 #antiviral #nasalspray #covid19 #pandemblock @NatureComms @pandemblock
https://t.co/oTHgEQbbpf

[Medicine and Health, University of Helsinki @HelsinkiUniMed]

Researchers @helsinkiuni have developed a molecule that is, when administered nasally, extremely effective in preventing the disease caused by all known variants of the SARS-CoV-2 virus. The molecule could be a key tool in preparing for future pandemics. 💪https://t.co/bgqNzfEWoy

[Medicine and Health, University of Helsinki @HelsinkiUniMed]

Tutkijat @helsinkiuni ovat kehittäneet molekyylin, joka nenään annosteltuna estää erittäin tehokkaasti koronaviruksen aiheuttaman taudin. Molekyyli toimii myös uusimpia immuunipuolustusta kiertäviä virusmuunnoksia vastaan.
#HyvätUutiset @Anna_R_Makela https://t.co/Pg45TOZtSS

[Eric Topol @EricTopol]

The #SARSCoV2🦠has been relentlessly evolving over the past 3 years to find new hosts. Its latest iteration, XBB.1.5, acquired a critical double mutation that maintains high level of immune escape while increasing infectivity
by @yunlong_cao and colleagues
https://t.co/32QqpChRVR

[Anna R. Mäkelä, PhD @Anna_R_Makela]

The answer blocking #SARSCoV2 may be up in the nose - nasal vaccines and antiviral inhibitors.
#covid19 #pandemic #ptotection #nasalvaccine #nasalinhibitor https://t.co/3TE2Jld9Em

[Anna R. Mäkelä, PhD @Anna_R_Makela]

"SARS-CoV-2 is rapidly mutating and recombining, and more (sub)variants—potentially more pathogenic—are on the horizon. The world is still barely vaccinated, and even in wealthy countries like the US, resources are inequitably distributed. It ain't over."
https://t.co/BWaOOBF9wE

[Anna R. Mäkelä, PhD @Anna_R_Makela]

Take a look at our innovative antiviral approach tackling respiratory virus infections using propiertary Sherpabody-binder protein technology.
https://t.co/nBspFdrZeF

#pandemblock #pandemicpreparedness #intranasal #antiviral #protection #sherpabody

[Pandemblock Oy @pandemblock]

#Pandemblock is developing self-administrable easy-to-use products to provide immediate #protection against a broad spectrum of #respiratoryvirus's. These innovative #antiviral inhibitors are based on proprietary #Sherpabody platform. #pandemicpreparedness
https://t.co/LuoGe7ouO7

[Anna R. Mäkelä, PhD @Anna_R_Makela]

Happy and Peaceful Easter! During the long weekend and vigorous egg hunt, I would like to invite you to take a tour of @Pandemblock´s website https://t.co/nBspFdrZeF & get introduced to our mission.
#pandemblock #pandemicpreparedness #antiviral #intranasal #protection #sherpabody

[Anna R. Mäkelä, PhD @Anna_R_Makela]

@MariToppinen @HelsinkiUniMed @ViromeLab Paljon onnea @MariToppinen !

[Medicine and Health, University of Helsinki @HelsinkiUniMed]

Lääkeyritykset kuskaavat valmistuneet rokotteet sinne, missä on rahaa. "Kysymys ei ole patenteista vaan ihmisten välisestä solidaarisuudesta", lataa virologian professori Kalle Saksela @yliopistolehti jutussa. https://t.co/4ta9Oa69z4

[University of Helsinki @helsinkiuni]

Tilanne Ukrainassa on huolestuttava ja liikkeellä on paljon virheellistä tietoa. Toimittaja: jos teet juttuja aiheesta, Venäjän tutkijamme auttavat mielellään tulkinnoissa! 🤝
#Ukraina #Putin #Venäjä #asiantuntijalista #WeAreHelsinkiUni
Soittele! 👇📞
https://t.co/TKojzQUSCv